The Best of Oncology East 2020 Conference is a digital meeting and will be held on Friday, November 20, 2020 from 8:00 AM - 3:10 PM EST.
This meeting highlights the top 3-4 most clinically relevant achievements of 2020 for several tumour sites; faculty will be drawn from some of the most influential oncologists across the country. Chaired by Dr. Scott Berry, Dr. Suneil Khanna and Dr. Dorothy Lo, this meeting will incorporate several multi-disciplinary event sessions addressing: radiation oncology, surgical oncology and support care.
• To discuss the pivotal oncology trials presented in the different disease sites
• To review the current standard of care for key malignancies
• To discuss the current controversies in the management of specific cancers
Registration will be complimentary for Healthcare professionals. Industry representatives (both sponsor and non-sponsor) can register by contacting Laura Davidson at firstname.lastname@example.org.
Dr. Scott Berry, BSc, MD, MHSc, FRCPC
Dr. Scott Berry is a medical oncologist and Professor and Department Head in the Queen's University Department of Oncology. He is the Cancer Program Medical Director at the Cancer Centre of Southeastern Ontario at the Kingston Health Sciences Centre.
Dr. Berry is an active participant in clinical research in GI cancer. He is the Co-Chair of the GI Disease Site Group of the CCO Program in Evidence Based Care.
Dr. Berry loves teaching, has won several teaching awards and is a past Chair of the Royal College of Physicians and Surgeons of Canada Specialty Committee for Medical Oncology
His other academic interest is the bioethical issues surrounding the care of people with cancer, in particular the ethical issues surrounding funding new and expensive cancer medications. Dr. Berry has a Master’s degree in Bioethics from the University of Toronto. He is the former ethics advisor to the pan-Canadian Oncology Drug Review and has served on the ASCO Ethics Committee.
Areas of specialization: Colorectal cancer, GI cancers, medical education, bioethics of cancer care
Dr. Suneil Khanna is a Medical Oncologist at the Mackenzie Health Hospital in Richmond Hill.
He completed his medical school at the University of Alberta, residency training at the University of Calgary, and Fellowship Training at Sunnybrook Health Sciences Centre, specializing in Gastrointestinal and Thoracic malignancies.
He has a special interest in clinical trials and medical education, and is the co-chair of the COMET Education Committee and a planning committee member for the annual MAGIC meeting.
Dr. Dorothy Lo graduated from U of T Faculty of Medicine, McMaster Internal Medicine Programme, and medical oncology residency at U of T. During residency, Dr. Lo started studies in MHSc-Health Administration at U of T and graduated in 2008. She contributed to research projects and publications in cancer diagnostic assessment programs as part of residency training and as part of her internship at CCO.
As a staff medical oncologist at SJHC since 2007, Dr. Lo has served as the Head of the Division of Haematology & Oncology since 2013. At SJHC, she has been the site Principle investigator for five clinical trials.
In the oncology community, Dr. Lo has been active as the co-chair of education for COMET since 2008. Dr. Lo previously served as the Secretary and then VP of the Haematology & Oncology Section of the OMA. She has an academic affiliation with U of T as an Adjunct Clinical Lecturer. Since 2015, Dr. Lo has been the Chair of the Partnership Series which focuses on building Communities of Practice to improve access and collaboration in cancer care. Outcomes data from the Partnership Series was presented at CAMO 2017 and published as two separate articles in 2018.
Over the last three years, her QI projects have focused on addressing barriers in the management of rarer tumor sites including NETS, quality performance indicators, incorporating real world evidence, and access and implementation of biosimilar products
For more information, please send requests to Laura Davidson email@example.com.
|8:00 a.m. - 8:45 a.m. EST||Knight Therapeutics - Optimizing metastatic HER2+ therapy – What are the treatment considerations? - Dr. Christine Brezden-Masley|
|8:45 a.m. - 9:00 a.m. EST||Welcome Address by Chairs - Dr. Scott Berry, Dr. Suneil Khanna, & Dr. Dorothy Lo|
|9:00 a.m. - 9:45 a.m. EST||Lung cancer - Dr. Jeff Rothenstein|
|9:45 a.m. - 10:15 a.m. EST||Melanoma - Dr. Parneet Cheema|
|10:15 a.m. - 10:25 a.m. EST||BREAK|
|10:25 a.m. - 11:10 a.m. EST||Mylan - The Future of Biosimilars in Oncology - Implementing the Lessons from Today- Dr. Stephen Chia|
|11:10 a.m. - 11:55 a.m. EST||GI - Colorectal and Non-Colorectal - Dr. Stephanie Snow|
|11:55 a.m. - 12:40 p.m. EST||GU - Prostate and Non-Prostate - TBC|
|12:40 p.m. - 1:00 p.m. EST||LUNCH|
|1:00 p.m. - 1:30 p.m. EST||Radiation Oncology Update: Management of Oligometastases - Dr. Alexander Louie|
|1:30 p.m. - 2:15 p.m. EST||Knight Therapeutics - Adjuvant HER2+ Therapy Treatment Landscape – Clinician Experience & Insights- Dr. Ruth O'Regan|
|2:15 p.m. - 3:00 p.m. EST||Breast Cancer - Dr. Sonal Gandhi|
|3:00 p.m. - 3:15 p.m. EST||Closing Remarks from Chairs - Dr. Scott Berry, Dr. Suneil Khanna, & Dr. Dorothy Lo|
For sponsorship-related inquiries, please contact Bernadette Gregoris, Director of Operations at firstname.lastname@example.org.